<code id='2A79C9D9E9'></code><style id='2A79C9D9E9'></style>
    • <acronym id='2A79C9D9E9'></acronym>
      <center id='2A79C9D9E9'><center id='2A79C9D9E9'><tfoot id='2A79C9D9E9'></tfoot></center><abbr id='2A79C9D9E9'><dir id='2A79C9D9E9'><tfoot id='2A79C9D9E9'></tfoot><noframes id='2A79C9D9E9'>

    • <optgroup id='2A79C9D9E9'><strike id='2A79C9D9E9'><sup id='2A79C9D9E9'></sup></strike><code id='2A79C9D9E9'></code></optgroup>
        1. <b id='2A79C9D9E9'><label id='2A79C9D9E9'><select id='2A79C9D9E9'><dt id='2A79C9D9E9'><span id='2A79C9D9E9'></span></dt></select></label></b><u id='2A79C9D9E9'></u>
          <i id='2A79C9D9E9'><strike id='2A79C9D9E9'><tt id='2A79C9D9E9'><pre id='2A79C9D9E9'></pre></tt></strike></i>

          focus

          knowledge

          Hepatitis C has a cure — but many Americans still lack access to it
          Hepatitis C has a cure — but many Americans still lack access to it

          AdobeIn2005,NickVoyleswasdiagnosedwithhepatitisCafterbeingreleasedfromfiveyearsofincarceration.Anurs

          read more
          Novo Holdings to buy drug manufacturer Catalent in $16.5B deal
          Novo Holdings to buy drug manufacturer Catalent in $16.5B deal

          CarstenSnejbjerg/BloombergLONDON—TheinvestmentarmofNovoNordisk’sparentfoundationisbuyingdrugmanufact

          read more
          Medicare details structure of new drug price negotiation program
          Medicare details structure of new drug price negotiation program

          MedicareonFridayreleasednewdetailsabouthowitsnewdrugpricenegotiationprogramwillwork,justtwomonthsbef

          read more

          Buoyed by wins on obesity, Novo Nordisk eyes heart disease

          AdobePHILADELPHIA—NovoNordisk,whichhasdominatedthediabetesandobesitymarketswithitsblockbusterdrugsOz